Month: November 2020

An exterior view of the U.S. Securities and Exchange Commission (SEC) headquarters in Washington. Jonathan Ernst | Reuters What would a Democrat-controlled Securities and Exchange Commission look like? It’s early, but speculation is already raging on Wall Street.  Who will be SEC commissioner? Gary Gensler, who aggressively implemented the Dodd-Frank Act when he was the
0 Comments
Plant-based biologics manufacturer iBio (NYSEAMERICAN:IBIO) is best known for its pipeline drug candidates, IBIO-200 and IBIO-201, which target Covid-19. Thus, when it comes to vaccine candidates, investors in IBIO stock should be encouraged that the company has not just one, but two “dogs in the race,” so to speak. Source: Shutterstock The company is also known
0 Comments
Facebook (NASDAQ:FB) stock surged by nearly 10% after Election Day 2020, as Democrats failed to materialize a blue wave. That jibes with investor concerns heading into the election, which were fueled by worries a Democrat-controlled government would install sweeping reform across the Big Tech landscape. Bad news for Facebook stock, right? Source: Cryptographer / Shutterstock.com
0 Comments
If there were one word to describe 2020, “volatile” would be an appropriate description. The coronavirus pandemic wreaked havoc on the U.S. economy. The broader economy remains in a highly uncertain position. With this backdrop, investors may want to position their portfolios to be less volatile moving forward by investing in low-beta stocks. Low-beta stocks
0 Comments
Eastman Kodak (NYSE:KODK) has had a long slow fall from grace. Since missing the evolution to digital photography, Kodak has struggled. The company filed bankruptcy 2012, and since emerging from reorganization, it has desperately swung from one half-baked business strategy to the next. For example, the less said of 2018’s Kodak cryptocurrency, the better. However,
0 Comments
Although e-commerce solutions provider Shopify (NYSE:SHOP) reported blowout third-quarter numbers in late October, which blew past expectations, Shopify stock still dropped after the print because the magnitude of the Q3 earnings beat was smaller than what the company reported in Q2. Source: Paul McKinnon / Shutterstock.com Specifically, Shopify topped Q2 earnings estimates by over a
0 Comments
Check out the companies making headlines midday on Monday: Pfizer, BioNTech — Pfizer and BioNTech jumped 7.7% and 13.9%, respectively, after the two companies released trial data that showed their coronavirus vaccine candidate had an efficacy rate of more than 90%. Dr. Albert Bourla, chairman and CEO of Pfizer, hailed the trial results as a
0 Comments